Quantcast

Latest Pneumococcal vaccine Stories

2008-12-19 12:23:00

Suggests adults with asthma should receive pneumococcal vaccine ROCHESTER, Minn., Dec. 19 /PRNewswire-USNewswire/ -- Mayo Clinic research shows adults with asthma are at increased risk of serious pneumococcal disease caused by Streptococcus pneumoniae, the most common bacteria causing middle ear infections and community acquired pneumonia. It also causes blood stream infections and brain infections. According to the Centers for Disease Control, pneumococcal infection is one of the leading...

2008-12-03 07:31:00

COLLEGEVILLE, Pa., Dec. 3 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that it has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMEA) for approval to market its investigational 13-valent pneumococcal conjugate vaccine (PCV13) for infants and young children. Wyeth is seeking an indication for the prevention of pneumococcal disease (PD) caused by the 13 serotypes included in the investigational...

2008-10-27 12:00:29

WASHINGTON, Oct. 27 /PRNewswire-FirstCall/ -- Data from a pivotal trial and three other Phase 3 studies presented today indicate that Wyeth's investigational 13-valent pneumococcal conjugate vaccine (PCV13) may offer broader protection against pneumococcal disease (PD) in infants and young children compared to Prevnar(R), Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein). Specifically, the data indicate that PCV13 may be as effective as Prevnar (also referred to as PCV7)...

2008-10-23 09:00:10

The U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) voted unanimously yesterday to recommend that adults ages 19 to 64 with asthma receive pneumococcal polysaccharide vaccine (PPSV23), known as PNEUMOVAX(R) 23 (Pneumococcal Vaccine Polyvalent). Merck & Co., Inc. is the sole supplier of PNEUMOVAX 23 in the United States. The ACIP based this recommendation on study data that showed an increased risk of pneumococcal disease among...

7cc8dff5c1bea6a0c998d234e5f1f33f1
2008-10-23 08:20:00

A vaccination to protect against the bacteria that can cause pneumonia, meningitis and other diseases is now available for smokers. A government panel recommends that adult smokers under the age of 65 be given the pneumococcal vaccine which is already administered to anyone 65 or older.  These pneumococcal infections affect the elderly in particular and are common complications of the flu and are top killers among the diseases that can be prevented by vaccination.  Smokers are...

2008-10-16 15:00:27

Britain's All-Party Parliamentary Group on Pneumococcal Disease Prevention officials say pneumococcal disease must be recognized as a global health issue. Between 700,000 and 1 million children under the age 5 die each year from pneumococcal disease and these child deaths are a largely preventable tragedy, the group says. A vaccine against pneumococcal disease exists and is being used in the Britain. The impact of this vaccine has been seen in England and Wales where there has been a 59...

66d855cc0c12026677d767a3bc1bb2991
2008-10-16 08:50:13

Pneumococcal disease, one of the world's leading causes of death and serious illness, must be recognized as an urgent global health issue together with HIV, malaria and TB, say the UK All-Party Parliamentary Group (APPG) on Pneumococcal Disease Prevention in the Developing World in a report launching at the House of Lords today. Between 700,000 and one million children under the age of five die each year from pneumococcal disease, equivalent to malaria and more than AIDS and tuberculosis....

2008-09-24 12:00:37

Wyeth Pharmaceuticals, a division of Wyeth, has initiated the community acquired pneumonia immunization trial in adults, a major study in adults of an investigational 13-valent conjugate vaccine designed to help prevent pneumococcal pneumonia. The results from this trial are not intended or required for inclusion in Wyeth's currently planned regulatory filings for the use of the 13-valent pneumococcal conjugate candidate vaccine in adults. Rather, this study is being initiated proactively...

2008-09-24 12:00:37

U.S. scientists say the discovery of a new mechanism of immunity suggests a more effective pneumococcal vaccine might be in the offing. Children's Hospital Boston and Harvard School of Public Health researchers say there might be a better way to protect people against Streptococcus pneumoniae infection. They said the current vaccine, Prevnar, is expensive and covers only 7 of the 91 known pneumococcal strains. Dr. Richard Malley and medical researcher Marc Lipsitch discovered that, in...

2008-09-23 09:00:15

COLLEGEVILLE, Pa., Sept. 23 /PRNewswire/ -- Wyeth Pharmaceuticals, a division of Wyeth , today announced the initiation of the Community Acquired Pneumonia Immunization Trial in Adults a major study in adults of an investigational 13-valent conjugate vaccine designed to help prevent pneumococcal pneumonia -- the leading cause of bacterial pneumonia in adults. In Europe and the United States, pneumococcal pneumonia is the most common community-acquired bacterial pneumonia, for which the...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related